Literature DB >> 21732985

Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum.

Masamoto Murakami, Eva Hagforsen, Vera Morhenn, Akemi Ishida-Yamamoto, Hajime Iizuka.   

Abstract

Recent findings about the pathogenesis of pustulosis palmaris et plantaris (PPP), also known as palmoplantar pustulosis, suggest that IL-17 expression in the acrosyringium as well as infiltration of IL-17 positive cells, e.g. Langerhans cells may play important roles. However, to date, it has not been established whether circulating IL-17 related cytokines are involved in PPP. We studied the circulating IL-17 related cytokines as well as the mRNA levels in lesional skin. IL-17 related cytokine mRNAs were increased in the PPP lesions compared with the control tissues (five patients vs five controls). The serum levels of TNF-alpha, IL-17, IL-22 and IFN-gamma also were significantly increased in PPP, but not IL-23 and IL-8 (48 patients vs 20 controls). Our findings document that not only the serum IL-17 but also tissue IL-17 are elevated in PPP and may be in the pathogenesis of this disorder.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732985     DOI: 10.1111/j.1600-0625.2011.01325.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  24 in total

Review 1.  [Pustular psoriasis].

Authors:  P Weisenseel; D Wilsmann-Theis; C Kahl; K Reich; R Mössner
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

Review 2.  [Pathogenesis of psoriasis].

Authors:  K Schäkel; M P Schön; K Ghoreschi
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

3.  Glycyrrhizin combined with acitretin improve clinical symptom of psoriasis via reducing Th17 cell differentiation and related serum cytokine concentrations.

Authors:  Wen-Zhong Wu; Fu-Ren Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Nummular dermatitis on guselkumab for palmoplantar psoriasis.

Authors:  Allison Truong; Stephanie Le; Maija Kiuru; Emanual Maverakis
Journal:  Dermatol Ther       Date:  2019-05-20       Impact factor: 2.851

5.  Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial.

Authors:  Tadashi Terui; Satomi Kobayashi; Yukari Okubo; Masamoto Murakami; Keiichiro Hirose; Hiroshi Kubo
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

Review 6.  The aryl hydrocarbon receptor: a review of its role in the physiology and pathology of the integument and its relationship to the tryptophan metabolism.

Authors:  Rowland Noakes
Journal:  Int J Tryptophan Res       Date:  2015-02-10

7.  Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis.

Authors:  Masamoto Murakami; Takaaki Kaneko; Teruaki Nakatsuji; Kenji Kameda; Hidenori Okazaki; Xiuju Dai; Yasushi Hanakawa; Mikiko Tohyama; Akemi Ishida-Yamamoto; Koji Sayama
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

8.  Microscopic Examination of Nail Clippings from Patients with Palmoplantar Pustulosis.

Authors:  Anber Ancel Tanaka; Betina Werner; Cassia Farris; Cassio Tornesy
Journal:  Dermatopathology (Basel)       Date:  2019-10-29

Review 9.  Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.

Authors:  Toshiyuki Yamamoto
Journal:  Clin Pharmacol       Date:  2021-06-23

10.  Interventions for chronic palmoplantar pustulosis.

Authors:  Grace Obeid; Giao Do; Lisa Kirby; Carolyn Hughes; Emilie Sbidian; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2020-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.